Physical Exercise as a Targeted Therapy in Patients With Chronic Rheumatic Muscle Inflammation
1 other identifier
interventional
30
1 country
1
Brief Summary
The objectives of this study are to test if hypoxia in muscle tissue is an important factor contributing to clinical symptoms in chronic rheumatic muscle inflammation and to evaluate if a 12 week endurance exercise program will improve muscle tissue hypoxia and disability in patients with chronic rheumatic muscle inflammation.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at below P25 for not_applicable
Started Jan 2008
Longer than P75 for not_applicable
1 active site
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
Study Start
First participant enrolled
January 1, 2008
CompletedFirst Submitted
Initial submission to the registry
August 17, 2010
CompletedFirst Posted
Study publicly available on registry
August 19, 2010
CompletedPrimary Completion
Last participant's last visit for primary outcome
January 1, 2012
CompletedStudy Completion
Last participant's last visit for all outcomes
August 1, 2012
CompletedJune 27, 2011
June 1, 2011
4 years
August 17, 2010
June 24, 2011
Conditions
Keywords
Outcome Measures
Primary Outcomes (2)
Hypoxia related metabolites.
At baseline before intervention.
Hypoxia related metabolites.
After 12 weeks of endurance exercise intervention/ non intervention.
Secondary Outcomes (2)
Muscle impairment.
At baseline before intervention.
Muscle impairment.
After 12 weeks of endurance exercise intervention/ non intervention.
Study Arms (2)
Exercise
EXPERIMENTALNo intervention
NO INTERVENTION12 weeks of stable physical exercise level.
Interventions
Eligibility Criteria
You may qualify if:
- Patients with chronic, stable polymyositis or dermatomyositis with diagnosis of definite or probable polymyositis or dermatomyositis (Bohan and Peter 1975)
- Age 18-80 years
- Duration since diagnosis \> 6 months
- Exercising \< once a week,
- Stable disease activity and medication for at least one month.
- Ten healthy controls matched for age, gender and physical exercise level will be included.
You may not qualify if:
- Severe pulmonary fibrosis
- Heart or lung conditions that contraindicate vigorous exercise
- Severe osteoporosis
- Not being able to perform the exercise program.
Contact the study team to confirm eligibility.
Sponsors & Collaborators
- Karolinska Institutetlead
- Uppsala University Hospitalcollaborator
- Sahlgrenska University Hospitalcollaborator
Study Sites (1)
Rheumatology unit, Karolinska University Hospital
Stockholm, Sweden
Related Publications (3)
Boehler JF, Hogarth MW, Barberio MD, Novak JS, Ghimbovschi S, Brown KJ, Alemo Munters L, Loell I, Chen YW, Gordish-Dressman H, Alexanderson H, Lundberg IE, Nagaraju K. Effect of endurance exercise on microRNAs in myositis skeletal muscle-A randomized controlled study. PLoS One. 2017 Aug 22;12(8):e0183292. doi: 10.1371/journal.pone.0183292. eCollection 2017.
PMID: 28829792DERIVEDAlemo Munters L, Dastmalchi M, Katz A, Esbjornsson M, Loell I, Hanna B, Liden M, Westerblad H, Lundberg IE, Alexanderson H. Improved exercise performance and increased aerobic capacity after endurance training of patients with stable polymyositis and dermatomyositis. Arthritis Res Ther. 2013 Aug 13;15(4):R83. doi: 10.1186/ar4263.
PMID: 23941324DERIVEDAlemo Munters L, Dastmalchi M, Andgren V, Emilson C, Bergegard J, Regardt M, Johansson A, Orefelt Tholander I, Hanna B, Liden M, Esbjornsson M, Alexanderson H. Improvement in health and possible reduction in disease activity using endurance exercise in patients with established polymyositis and dermatomyositis: a multicenter randomized controlled trial with a 1-year open extension followup. Arthritis Care Res (Hoboken). 2013 Dec;65(12):1959-68. doi: 10.1002/acr.22068.
PMID: 23861241DERIVED
MeSH Terms
Conditions
Interventions
Condition Hierarchy (Ancestors)
Intervention Hierarchy (Ancestors)
Study Officials
- PRINCIPAL INVESTIGATOR
Ingrid E Lundberg, MD, PhD, Prof
Rheumatology Unit, Department of Medicine, in Solna, Karolinska Institutet
Central Study Contacts
Study Design
- Study Type
- interventional
- Phase
- not applicable
- Allocation
- RANDOMIZED
- Masking
- SINGLE
- Who Masked
- OUTCOMES ASSESSOR
- Purpose
- TREATMENT
- Intervention Model
- PARALLEL
- Sponsor Type
- OTHER
Study Record Dates
First Submitted
August 17, 2010
First Posted
August 19, 2010
Study Start
January 1, 2008
Primary Completion
January 1, 2012
Study Completion
August 1, 2012
Last Updated
June 27, 2011
Record last verified: 2011-06